Korro Bio is a biotechnology company focused on developing novel gene editing technologies to advance precision medicine and transform the treatment of genetic diseases. Founded in 2018, Korro Bio's innovative approaches have the potential to revolutionize the field of genetic medicine and bring about new therapeutic solutions for patients worldwide.

Director, Toxicology

Director, Analytical Development - Oligonucleotide

Associate Director of Manufacturing Sciences

Associate Scientist, Disease Area Biology

Senior Director, Clinical Development

Associate Director/Director, Quality Assurance

SEC Reporting Manager

Senior Manager, Strategy and Portfolio Planning

RNA Therapeutics Scientist

korro-bio

Refer new talent to Korro Bio